Stockscreener 앱 받기
1.72
4.40%
-0.09
Hoth Therapeutics Inc 주식(HOTH)의 최신 뉴스
EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart.com
Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com Nigeria
Hoth expands HT-001 development with patents for cancer therapy side effects By Investing.com - Investing.com South Africa
Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener
Novel Drug Could Help Cancer Patients Stay on Life-Saving Treatments: Hoth's HT-001 Targets Multiple Skin Effects - Stock Titan
Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance
Chart Watch: Can Hoth Therapeutics Inc stock double in the next year2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک
Bull Run: Will Hoth Therapeutics Inc benefit from rising consumer demandMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک
New Highs: Whats the MACD signal for Hoth Therapeutics IncWeekly Trend Recap & Proven Capital Preservation Tips - خودرو بانک
Risks Report: Whats the outlook for Hoth Therapeutics Incs sectorWeekly Trading Summary & Daily Price Action Insights - خودرو بانک
Market Review: Is NGVT a momentum stockMarket Weekly Review & Risk Controlled Swing Alerts - khodrobank.com
Is Hoth Therapeutics Inc benefiting from innovation trendsEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Market Outlook: Will Hoth Therapeutics Inc. announce a stock splitQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - خودرو بانک
Aug Shorts: How correlated is Hoth Therapeutics Inc to the S P500July 2025 Big Picture & Expert Verified Movement Alerts - خودرو بانک
Risk Analysis: What are the future prospects of NEEPRTTrade Ideas & Real-Time Sentiment Analysis - خودرو بانک
Take Profit: Will Hoth Therapeutics Inc benefit from rising consumer demand2025 Risk Factors & High Conviction Buy Zone Picks - خودرو بانک
Risk Hedge: Is Monster Beverage Corporation a defensive stockProduct Launch & Daily Risk Controlled Trade Plans - خودرو بانک
Hoth Therapeutics issues update- HT-001, HT-KIT, VA Obesity Program drive strongest position in company history - MarketScreener
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History - PR Newswire
Support Test: What is the dividend yield of Hoth Therapeutics Inc2025 Biggest Moves & Entry Point Confirmation Signals - خودرو بانک
$1M Crypto Treasury Plan: Hoth Therapeutics Expands Global Trial Network While Adding Bitcoin Strategy - Stock Titan
Risk Off: What is Hoth Therapeutics Inc. s debt to equity ratioJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - خودرو بانک
What MACD and RSI say about Hoth Therapeutics Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Will Hoth Therapeutics Inc. announce a stock splitMarket Trend Report & Weekly Consistent Profit Watchlists - خودرو بانک
Stock Report: What is the dividend yield of Hoth Therapeutics IncCPI Data & Trade Opportunity Analysis Reports - خودرو بانک
Hoth Therapeutics climbs on $1 million crypto reserve plan - TradingView
Hoth Therapeutics climbs on $1 mln crypto reserve plan - TradingView
Hoth Therapeutics approved expansion of treasury reserve strategy to include Ethereum and Solana - MarketScreener
Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease - 富途牛牛
Hoth Therapeutics submits European application for skin toxicity drug - Investing.com
Hoth Therapeutics submits European application for skin toxicity drug By Investing.com - Investing.com Nigeria
Hoth Therapeutics reaches EMA milestone for HT-001 phase II trial targeting EGFRi-linked skin toxicities - MarketScreener
Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities - WV News
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MarketBeat
Chart Analysts Warn of Resistance Near Hoth Therapeutics Inc. PriceJuly 2025 Market Mood & Capital Efficiency Focused Ideas - beatles.ru
How does Hoth Therapeutics Inc. correlate with NasdaqWeekly Trend Summary & High Win Rate Trade Tips - classian.co.kr
Earnings visualization tools for Hoth Therapeutics Inc.2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
Can Hoth Therapeutics Inc. stock double in the next year2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Published on: 2025-09-06 01:25:14 - خودرو بانک
Hoth Therapeutics shares fall 2.24% premarket after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
Is Hoth Therapeutics Inc. building a consolidation basePortfolio Profit Report & Weekly Hot Stock Watchlists - Newser
Is Hoth Therapeutics Inc. trending in predictive chart modelsPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Hoth Therapeutics adopts AI platform to advance drug development By Investing.com - Investing.com Canada
Is Hoth Therapeutics Inc. a momentum stockRate Cut & Risk Managed Investment Entry Signals - خودرو بانک
Hoth Therapeutics adopts AI platform to advance drug development - Investing.com India
Hoth Therapeutics shares fall 1.49% after-hours after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
What indicators show strength in Hoth Therapeutics Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser
Lantern Pharma shares fall 1.52% intraday after FDA meeting and Hoth Therapeutics partnership. - AInvest
Using AI based signals to follow Hoth Therapeutics Inc.2025 Momentum Check & Free Community Consensus Stock Picks - Newser
AI-Driven Drug Development: Hoth Therapeutics and Lantern Pharma’s Strategic Partnership to Revolutionize CNS Therapies - AInvest
Lantern Pharma's PredictBBB.ai Platform to Drive Next-Gen Drug Development with Hoth Therapeutics Partnership - AInvest
Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development - PR Newswire
Is Hoth Therapeutics Inc. benefiting from innovation trendsWeekly Profit Analysis & Smart Investment Allocation Tips - خودرو بانک
Exit strategy if you’re trapped in Hoth Therapeutics Inc.Market Activity Recap & Proven Capital Preservation Tips - Newser
Why Hoth Therapeutics Inc. is moving todayMarket Activity Summary & Daily Stock Momentum Reports - Newser
How to build a custom watchlist for Hoth Therapeutics Inc.Earnings Overview Summary & Long-Term Safe Investment Plans - Newser
Hoth Therapeutics Inc. stock daily chart insightsJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Is Hoth Therapeutics Inc. stock poised for growthExit Point & Reliable Price Breakout Alerts - Newser
Forecasting Hoth Therapeutics Inc. price range with options dataOptions Play & Step-by-Step Trade Execution Guides - Newser
Has Hoth Therapeutics Inc. found a price floorGold Moves & Precise Entry and Exit Recommendations - Newser
Hoth Therapeutics Inc. stock trend outlook and recovery pathVolume Spike & Free Daily Entry Point Trade Alerts - Newser
Real time breakdown of Hoth Therapeutics Inc. stock performanceMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
What momentum shifts mean for Hoth Therapeutics Inc.Insider Buying & Reliable Momentum Entry Alerts - Newser
4.24%
0.69%
자본화:
|
볼륨(24시간):